Clinical Proof of Concept (POC) of A Novel Dual-acting Glucokinase Activator (GKA) Achieved: HMS5552 improved glycemic control in T2DM Patients

2017 June
Hua Medicine
Jun 09, 2017
717

Online link unavailable, presentationavailable upon request. (BD@huamedicine.com)

Focus Us
Copyright © 2020  Hua Medicine (Shanghai) Co., Ltd. 沪ICP备14036654号    beiantubiao.png 沪公网安备 31011502013809号
Search